Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Find out how a multidisciplinary team of scientists came to create England's new way to identify how to fight and track TB outbreaks using DNA analysis.

Interviewees in order of appearance:

  • Dr Nicola Fawcett: Clinical Research Fellow and a Doctor in Acute and General Medicine; Nicola studies antibiotic prescribing and the effects on antimicrobial resistance in the gut bacteria.
  • Dr Jessica Hedge: Population Geneticist; Jessica studies how DNA analysis can be used to understand how bacteria evolve and develop drug resistance.
  • Dr Timothy Walker: Academic Clinical Lecturer and Doctor in Microbiology/Infectious Diseases; Timothy studies how DNA analysis can be used to predict drug resistance, understand transmission of infections,  and inform patient care.
  • Professor Derrick Crook: Research Group Lead and Direct of the National Infection Service at Public Health England; Derrick has led the group in pioneering the use of DNA analysis from laboratory to patient care.
  • Dr Dilrini de Silva: Bioinformatician; Dilrini designs and performs complex, large scale computational analyses of bacterial DNA to provide information on drug resistance and transmission of infections.

Read more about the study (as well as the original paper) on the Modernising Medical Microbiology website.

Derrick Crook

Infectious Diseases & Microbiology

Professor Derrick Crook developed a research programme in translating whole genome sequencing of pathogens and linkage of patient data contained in hospital databases. By linking whole genomic typing of pathogens with this patient data, his research is leading to more rapid and effective diagnosis, management and tracking of common infections such as MRSA (methicillin-resistant Staphylococcus aureus), Clostridium difficile, Tuberculosis and Norovirus.